Effects of female genital schistosomiasis on women's health in Tanzania

Genital Immune, Mucosal, and Viral Effects of Female Genital Schistosomiasis in Tanzania

NIH-funded research Weill Medical Coll of Cornell Univ · NIH-11041048

This study is looking at how a parasitic infection called female genital schistosomiasis affects the health of women in Tanzania, especially how it impacts their immune system and causes problems like pain and infertility, with the goal of finding better ways to help those who are suffering.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11041048 on NIH RePORTER

What this research studies

This research investigates the impact of female genital schistosomiasis, a disease caused by a parasitic worm, on the health of women in Tanzania. It focuses on how the parasite affects the immune response and causes damage to the genital tract, leading to symptoms such as pain, bleeding, and infertility. The study aims to understand the immune cells involved and how the disease may increase vulnerability to other infections. By addressing these issues, the research seeks to develop better treatments and interventions for affected women.

Who could benefit from this research

Good fit: Ideal candidates for this research are women in Tanzania who have been diagnosed with female genital schistosomiasis and are experiencing related health issues.

Not a fit: Patients who do not have female genital schistosomiasis or those who are not experiencing any symptoms related to the condition may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments that restore genital health and reduce complications for women suffering from this condition.

How similar studies have performed: Previous research on schistosomiasis and its effects on health has shown promising results, indicating that understanding the immune response can lead to effective interventions.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.